ProMIS Neurosciences Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.03 |
Market Cap |
$42.35 M |
Shares Outstanding |
246.13 M |
Public Float |
- |
ProMIS Neurosciences Inc. | |
Stock Exchange | Toronto Stock Exchange Prices |
EPS |
CAD0.05 |
Market Cap |
CAD52.28 M |
Shares Outstanding |
181.72 M |
Public Float |
153.45 M |
Address |
1920 Yonge Street Toronto Ontario M4S 3E2 Canada |
Employees | - |
Website | http://www.promisneurosciences.com |
Updated | 07/08/2019 |
ProMIS Neurosciences, Inc. operates as a development stage biotech company. It discovers and develops precision therapeutics and companion diagnostics for early detection and effective treatment of neurodegenerative diseases, in particular Alzheimer's disease and amyotrophic lateral sclerosis. The company was founded by Neil Cashman and Vigen Nazarian on January 23, 2004 and is headquartered in Toronto, Canada. |